Depression, antidepressants and suicidality: A critical appraisal

Julio Licinio, Ma Li Wong

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Regulatory agencies in the United Kingdom and United States have been critically examining the possible link between suicidality and antidepressant use in children and adults, which has resulted in an FDA directive to the manufacturers of all antidepressant medications to add a 'black box' warning that describes the increased risk of suicidal behaviour in children and adolescents who take antidepressants. A crucial issue in this debate, as we discuss here, is the assessment of the capacity of antidepressants to increase suicidality over and above what is caused by the underlying disorder, major depression, which is itself the principal cause of suicide.

LanguageEnglish
Pages165-171
Number of pages7
JournalNature Reviews Drug Discovery
Volume4
Issue number2
DOIs
Publication statusPublished - 1 Feb 2005

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Licinio, Julio ; Wong, Ma Li. / Depression, antidepressants and suicidality : A critical appraisal. In: Nature Reviews Drug Discovery. 2005 ; Vol. 4, No. 2. pp. 165-171.
@article{8ce47170b3ad42e08cad44b43bf6dabc,
title = "Depression, antidepressants and suicidality: A critical appraisal",
abstract = "Regulatory agencies in the United Kingdom and United States have been critically examining the possible link between suicidality and antidepressant use in children and adults, which has resulted in an FDA directive to the manufacturers of all antidepressant medications to add a 'black box' warning that describes the increased risk of suicidal behaviour in children and adolescents who take antidepressants. A crucial issue in this debate, as we discuss here, is the assessment of the capacity of antidepressants to increase suicidality over and above what is caused by the underlying disorder, major depression, which is itself the principal cause of suicide.",
author = "Julio Licinio and Wong, {Ma Li}",
year = "2005",
month = "2",
day = "1",
doi = "10.1038/nrd1634",
language = "English",
volume = "4",
pages = "165--171",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Publishing Group",
number = "2",

}

Depression, antidepressants and suicidality : A critical appraisal. / Licinio, Julio; Wong, Ma Li.

In: Nature Reviews Drug Discovery, Vol. 4, No. 2, 01.02.2005, p. 165-171.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Depression, antidepressants and suicidality

T2 - Nature Reviews Drug Discovery

AU - Licinio, Julio

AU - Wong, Ma Li

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Regulatory agencies in the United Kingdom and United States have been critically examining the possible link between suicidality and antidepressant use in children and adults, which has resulted in an FDA directive to the manufacturers of all antidepressant medications to add a 'black box' warning that describes the increased risk of suicidal behaviour in children and adolescents who take antidepressants. A crucial issue in this debate, as we discuss here, is the assessment of the capacity of antidepressants to increase suicidality over and above what is caused by the underlying disorder, major depression, which is itself the principal cause of suicide.

AB - Regulatory agencies in the United Kingdom and United States have been critically examining the possible link between suicidality and antidepressant use in children and adults, which has resulted in an FDA directive to the manufacturers of all antidepressant medications to add a 'black box' warning that describes the increased risk of suicidal behaviour in children and adolescents who take antidepressants. A crucial issue in this debate, as we discuss here, is the assessment of the capacity of antidepressants to increase suicidality over and above what is caused by the underlying disorder, major depression, which is itself the principal cause of suicide.

UR - http://www.scopus.com/inward/record.url?scp=14044257276&partnerID=8YFLogxK

U2 - 10.1038/nrd1634

DO - 10.1038/nrd1634

M3 - Article

VL - 4

SP - 165

EP - 171

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 2

ER -